نتایج جستجو برای: peginterferon alfa
تعداد نتایج: 19203 فیلتر نتایج به سال:
conclusions adding low dose of ribavirin to peg ifn alfa-2a for treatment of chronic hepatitis c patients with genotype-1 was “highly cost effective” and in patients with low viral load and in previous monotherapy resistant patients was “cost effective.” results the incremental cost effectiveness ratio (icer) for combination therapy in genotype-1 and genotypes non-1 subgroups was 2,673 and 19,2...
Chronic infection with hepatitis C virus (HCV) is estimated to affect approximately 3% of the world's population and cause 350,000 deaths each year. For a number of years, the standard of care has been combination therapy with recombinant alfa interferons-originally as native proteins but more recently as polyethyleneglycol-modified derivatives-and ribavirin, with the recent addition of an NS3 ...
BACKGROUND/AIMS Chronic hepatitis C patients with advanced fibrosis have unsatisfactory sustained virological response (SVR) rates. Few data demonstrating the efficacy of combination therapy in chronic hepatitis C patients with advanced fibrosis in South Korea are available. The purpose of this study was to assess whether the stage of fibrosis impacts the efficacy of combination therapy for chr...
AIM Biochemical and ultrasound investigations in patients with chronic hepatitis C on a 48-week anti-viral regimen. MATERIAL AND METHODS A group of 6 patients, 4 women and 2 men, age range 24-61, were evaluated at the beginning of therapy and compared after 48 weeks of peginterferon alfa-2a and peginterferon alpha-2b regimen at doses established by the National Treatment Program approved by t...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید